Nature communications

WEE1 blockers may activate the cell stress response through GCN2

Updated

Abstract

Essence

triggered a GCN2-dependent separate from their cell-cycle checkpoint effects.

Evidence

This mechanistic cell study used genome-wide insertional mutagenesis and CRISPR-Cas9 screens plus cancer and non-transformed cell experiments to map WEE1i cytotoxicity, ISR activation, ribosome dynamics, and low-dose or combination treatment effects.

Caveat

The work is cell-based and points to off-target GCN2 engagement by multiple WEE1 inhibitors, so dosing and combination implications remain preclinical.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Competing interests: D.D. and F.S. are shareholders and advisors for Repare Therapeutics. M.A.T.M.v.V. acted on the Scientific Advisory Board of Repare Therapeutics. The remaining authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free